Evidence map›Paper›PMID 25586634›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Blockade of the GLT-1 Transporter in the Central Nucleus of the Amygdala Induces both Anxiety and Depressive-Like Symptoms.

Catherine S John, Elizabeth I Sypek, William A Carlezon, Bruce M Cohen, Dost Öngür, Anita J Bechtholt

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Brain network localization of anhedonia.Translational psychiatry · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Astrocytes in Rodent Anxiety-Related Behavior: Role of Calcium and Beyond.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Catherine S JohnDepartment of Psychiatry, Harvard Medical School-McLean Hospital, Belmont, MA, USA.
Elizabeth I SypekDepartment of Psychiatry, Harvard Medical School-McLean Hospital, Belmont, MA, USA.
William A CarlezonDepartment of Psychiatry, Harvard Medical School-McLean Hospital, Belmont, MA, USA.
Bruce M CohenDepartment of Psychiatry, Harvard Medical School-McLean Hospital, Belmont, MA, USA.
Dost ÖngürDepartment of Psychiatry, Harvard Medical School-McLean Hospital, Belmont, MA, USA.
Anita J BechtholtNational Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA.
McLean Hospital · USHarvard University · USNational Institute on Alcohol Abuse and Alcoholism · US

Funding

Roles of nuleus accumbens CREB and Kappa function in depressionR01MH063266 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI CARLEZON, WILLIAM A. · 2001 to 2025
$9.1M
Dysregulation of glial glutamate transmission as a model of depressive illnessR03MH087695 · NIMH · MCLEAN HOSPITAL · PI BECHTHOLT, ANITA JEAN · 2010 to 2011
$158k
NIMH NIH HHS MH063266NIMH NIH HHS MH087695NIMH NIH HHS R01 MH063266NIMH NIH HHS R03 MH087695
6 · The paper itself

Abstract

Depression has been associated with abnormalities in glutamatergic neurotransmission and decreased astrocyte number in limbic areas. We previously demonstrated that global and prefrontal cortical blockade of the astrocytic glutamate transporter (GLT-1) induces anhedonia and c-Fos expression in areas that regulate anxiety, including the central amygdala (CEA). Given the role of the amygdala in anxiety and the high degree of comorbidity between anxiety and depression, we hypothesized that GLT-1 blockade in the CEA would induce symptoms of anhedonia and anxiety in rats. We microinjected the GLT-1 inhibitor, dihydrokainic acid (DHK), into the CEA and examined effects on intracranial self-stimulation (ICSS) as an index of hedonic state, and on behavior in two anxiety paradigms, elevated plus maze (EPM) and fear conditioning. At lower doses, intra-CEA DHK produced modest increases in ICSS responding (T0). Higher doses resulted in complete cessation of responding for 15 min, suggesting an anhedonic or depressive-like effect. Intra-CEA DHK also increased anxiety-like behavior such that percent time in the open arms and total entries were decreased in the EPM and acquisition of freezing behavior to the tone was increased in a fear-conditioning paradigm. These effects did not appear to be explained by non-specific changes in activity, because effects on fear conditioning were assessed in a drug-free state, and a separate activity test showed no significant effects of intra-CEA DHK on locomotion. Taken together, these studies suggest that blockade of GLT-1 in the CEA is sufficient to induce both anhedonia and anxiety and therefore that a lack of glutamate uptake resulting from glial deficits may contribute to the comorbidity of depression and anxiety.

Indexed as

AnimalsAnxietyCentral Amygdaloid NucleusConditioning, PsychologicalDepressionDisease Models, AnimalDose-Response Relationship, DrugElectric StimulationExcitatory Amino Acid Transporter 2FearKainic AcidMaleMaze LearningRatsRats, Sprague-DawleySelf Administrationdihydrokainic acidExcitatory Amino Acid Transporter 2Kainic AcidSlc1a2 protein, rat

Identifiers

PMID25586634
PMCPMC4915252
OpenAlexW2075299105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.